Current Drug Delivery
Title:Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease
Volume: 15 Issue: 6
Author(s): Giovanna Rassu, Elisabetta Gavini, Antonio Carta, Antonella Obinu, Elena Piera Porcu and Paolo Giunchedi*
Affiliation:
- Department of Chemistry and Pharmacy, University of Sassari, Sassari,Italy
Export Options
About this article
Cite this article as:
Rassu Giovanna , Gavini Elisabetta , Carta Antonio , Obinu Antonella , Porcu Piera Elena and Giunchedi Paolo *, Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease, Current Drug Delivery 2018; 15 (6) . https://dx.doi.org/10.2174/1567201814666171019104509
DOI https://dx.doi.org/10.2174/1567201814666171019104509 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mental Training for Cognitive Improvement in Elderly People: What have We Learned from Clinical and Neurophysiologic Studies?
Current Alzheimer Research The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease
Current Genomics High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
Current Alzheimer Research Overcoming Chondroitin Sulphate Proteoglycan Inhibition of Axon Growth in the Injured Brain: Lessons from Chondroitinase ABC
Current Pharmaceutical Design The Cytokine Network in HIV Infection
Current Molecular Medicine Immunomodulatory Effects of Medicinal Plants used for Vitiligo in Traditional Persian Medicine
Current Drug Discovery Technologies Role of Metallothionein in Inflammatory Lung Diseases
Current Respiratory Medicine Reviews Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology Editorial (Hot Topic: The State of the Art in Diagnosis and Treatment of Soft Bipolar Disorders)
Current Psychiatry Reviews Commentary [The Mood in the Field of Antidepressant Drug Discovery]
CNS & Neurological Disorders - Drug Targets New Psychoactive Substances: A Matter of Time
Current Neuropharmacology Apoptosis in Alzheimer Disease: A Mathematical Improbability
Current Alzheimer Research GSK3β 5'-flanking DNA Methylation and Expression in Alzheimer’s Disease Patients
Current Alzheimer Research Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets The Effect of Acori Graminei Rhizoma and Extract Fractions on Spatial Memory and Hippocampal Neurogenesis in Amyloid Beta 1-42 Injected Mice
CNS & Neurological Disorders - Drug Targets Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome
CNS & Neurological Disorders - Drug Targets Towards an Experimental and Systems Biology Framework for Cancer Cell Therapeutics
Current Bioinformatics The Urokinase Receptor Interactome
Current Pharmaceutical Design Review of Interventions for Parental Depression from Toddlerhood to Adolescence
Current Psychiatry Reviews Involvement of μ-Opioid Receptor in Methamphetamine-Induced Behavioral Sensitization
Current Neuropharmacology